[Therapeutic efficacy of mildronate in pulmonary diseases].
Immuno-corrective action of the medication has been proved by analyzing Mildronate administration in 64 patients with bronchial asthma and secondary immunodeficiency. Stimulation of sell component and inhibition of humoral component of the immunity system, improvement of central hemodynamics and normalization of the hemopoiesis system to some extent have been observed in the patients. The patients with chronic catarrhal obstructive bronchitis in acute stage and patients with infection-allergic bronchial asthma showed decrease in bronchial obstruction under the treatment with the medication.
V P
VP
Mkrtchian
V A
VA
Orlov
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000188:drug therapy* / Q000276:immunology; D008763:Methylhydrazines / Q000627:therapeutic use*
D000276:Adjuvants, Immunologic; D008763:Methylhydrazines; C050147:3-(2,2,2-trimethylhydrazine)propionate